Related Experiment Videos
[Tumor markers in cervical carcinoma].
Revista Espanola De Oncologia
|January 1, 1985
Summary
Four tumor markers, including CEA and alpha-FP, can differentiate preinvasive and invasive gynecologic tumors. Other markers like TPA and LDH-V showed no value in distinguishing these tumor types.
Area of Science:
- Gynecologic oncology
- Tumor marker diagnostics
Context:
- Distinguishing between preinvasive and invasive gynecologic tumors is crucial for effective treatment planning.
- Accurate diagnostic tools are needed to identify tumor stage and guide clinical decisions.
Purpose:
- To evaluate the efficacy of seven tumor markers in differentiating preinvasive from invasive gynecologic tumors.
- To identify reliable biomarkers for gynecologic tumor staging.
Summary:
- Carcinogenic embryonic antigen (CEA), beta-chorionic gonadotropin (beta-hCG), alpha-fetoprotein (alpha-FP), and the alpha-glycoprotein/prealbumin quotient demonstrated utility in differentiating preinvasive and invasive gynecologic tumors.
- Tissue polypeptide antigen (TPA), lactate dehydrogenase-V (LDH-V), and prolactin (PRL) were found to be ineffective as markers for distinguishing between these gynecologic tumor stages.
Impact:
- This study identifies specific tumor markers that can aid in the accurate diagnosis and staging of gynecologic malignancies.
- The findings can help refine diagnostic strategies, potentially leading to improved patient management and outcomes.